The invention relates to methods for in vitro diagnosis of acute coronary syndrome (ACS), acute myocardial infarction (AMI) or angina pectoris (AP) by determining the level of neurophysin II in a sample from a patient.
Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II